PechaKucha-based education to help chemotherapy patients manage symptoms and quality of life
Official title: The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
Run by Istanbul Aydın University · NCT07769931 · Data updated 2026-11-12
A randomized trial tests whether a 6 minute and 40 second PechaKucha video education session helps adults undergoing chemotherapy manage symptoms and improve quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Istanbul Aydın University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Istanbul, Istanbul) |
| Status | Recruiting |
| Started | June 3, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07769931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older currently receiving chemotherapy who can communicate effectively and do not have major cognitive, sensory, or terminal-illness barriers.
✕Probably not a fit
Patients with severe cognitive or sensory impairments, terminal illness, or conditions preventing participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares PechaKucha-based symptom management education with routine education in adults receiving chemotherapy. The intervention uses a concise 20-slide video to teach symptom management topics, delivered individually. Outcomes are symptom burden and quality of life, measured at baseline and about one week later with ESAS and EQ-5D. Participants are recruited from a university hospital chemotherapy unit and randomized to either the PechaKucha education or standard care.
Why it matters
Potential benefit: If successful, patients may experience better symptom control and higher quality of life during chemotherapy.
How similar studies have gone: Previous work in educational approaches suggests multimedia formats can improve understanding and patient-reported outcomes, but PechaKucha-based methods are relatively novel in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing to participate in the study. * Currently receiving treatment in the chemotherapy unit. * Aged 18 years or older, willing to participate, and able to communicate effectively. Exclusion Criteria: * Being under 18 years of age. * Having cognitive or communication difficulties. * Having a visual or hearing impairment. * Being in an advanced or terminal stage of the disease. * Having a physical or psychological condition that prevents active participation in the educational process.
Where it's running
-
SBÜ Kanuni Sultan Süleyman E.A.H
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Asiye TAN, Ph D
- Email: asiyetan@aydin.edu.tr
- Phone: 05055675275
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
One-Page Truth-Telling Aid to Guide Cancer Discussions
A one-page tool is tested to help doctors quickly understand a cancer patient’s information preferences before a consultation.
-
MST-168 first-in-human test in adults with advanced solid tumors
This early-phase study tests MST-168 in adults with target-driven advanced solid tumors to see if it is safe and tolerable and to gather initial signals of activity.
-
xDRIVE personalized tumor testing for Florida cancer patients
This program will try a functional precision medicine and AI platform (xDRIVE) to help guide next treatment options for Florida patients with recurrent or refractory cancer, including children and people from underserved communities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.